一緒に対処する: がんに対するカップルベースの介入 (CCST2)
進行がんのためのカップルコミュニケーションスキルトレーニング
The objective of the proposed study is to evaluate the Couple Communication Skills Training (CCST) intervention in 250 patients with advanced cancer and their spouses/intimate partners. Couples will be randomized 1:1 to receive either the CCST or to an attention control condition (Healthy Living Information; HLI). We will evaluate CCST effects on a range of patient and partner relationship and psychological outcomes.
調査の概要
詳細な説明
For patients and their intimate partners, advanced cancer poses significant challenges that can negatively impact both individuals and the couple's collective well-being. Couples' ability to communicate openly and effectively with each other about cancer-related concerns can improve their psychological adjustment and quality of their relationship. Open and effective communication may also lead to better symptom management and goal-concordant care. However, many couples report difficulties communicating about cancer, even in the context of overall satisfying relationships. This can have a number of deleterious consequences, including deficits in emotional support, decreases in intimacy and relationship quality, and increased psychological distress. Thus, interventions designed to facilitate effective communication between cancer patients and their partners are likely to have beneficial effects on both individual and relationship functioning.
Prior research, including studies conducted by our team, has found that couple-based interventions that target communication lead to positive outcomes for cancer patients and their partners. However, most prior studies have been limited by reliance on an in-person treatment delivery format which keeps many couples from participating. In addition, prior studies have not targeted interventions to couples who are most likely to benefit. There is increasing evidence that psychosocial interventions for cancer, including couple-based interventions, should be targeted to those at risk of poor outcomes. Our prior research indicates that couples who report communication difficulties (e.g., high levels of holding back from discussing cancer-related concerns) have increased psychological distress and poorer relationship functioning and are most likely to benefit from a couple communication intervention specifically designed to addressed their communication problems.
The specific aims of this study are (1)To determine whether CCST significantly improves patients' and partners' individual psychological adjustment (i.e., psychological distress, life completion) and patient health and health care outcomes (physical well-being, symptom distress, advance care planning discussions and completion of advance directives, hospitalizations, and emergency department visits) compared to an education condition. (2) To determine whether, for couples receiving the CCST intervention, improvements in psychological adjustment, relationship functioning, and patient health are mediated by improvements in their communication, including objective measures of communication quality and communal coping (e.g., "we-talk") derived from couple conversations and self-reported protective buffering. (3) To examine differences in response to the CCST intervention for patients versus partners, for male versus female participants, and for patients with different cancer diagnoses (breast, lung, GI, GU). (4) To conduct an implementation-related process evaluation of the intervention.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
North Carolina
-
Durham、North Carolina、アメリカ、27705
- Duke University Medical Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Married or in a committed intimate relationship
- Diagnosis of one the following advanced cancers: Stage IIIB or IV non-small cell lung cancer or extensive stage small cell lung cancer, Stage III pancreatic cancer or Stage IV GI cancer, Stage IV GU cancer, Stage IV breast cancer and GYN cancer Stage III-IV ovarian, IV uterine, IV cervical.
- Both members of the couple must speak and read English.
- Patient and/or partner scores >=1.0 on the Holding Back screen.
Exclusion Criteria:
- Patient lacks capacity for interview (documented diagnosis of active psychosis or dementia) or is unable to provide informed consent as assessed by research staff.
- Patient has a life expectancy < 6 months as estimated by his/her treating oncologist.
- Patient or partner is physically impaired in such a way that precludes the use of a computer or videoconferencing.
- Patient or partner is too sick to participate, as judged by the oncologist or research staff.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
他の:Couple Communication and Support
CCST includes components to assist couples in communicating effectively, decreasing avoidance of important cancer-related issues, and providing each other with support. It includes training in skills for sharing one's thoughts and feelings and listening to one's partner and responding in a supportive manner, and joint problem solving. Participants will be asked to participate inactivities at home between sessions to strengthen skills acquisition. |
Participants attend six 60-minute sessions consisting of education and skills training to enhance cancer-related communication.
他の名前:
|
|
他の:Healthy Lifestyle Informaion
Healthy Lifestyle Information provides couples with health information relevant to cancer in a supportive environment. Sessions focus on the following topics: fatigue, sleep disturbance, nutrition, physical activity, survivorship care plans, and palliative care. Patients and partners are invited to discuss their experiences around the session topics with the therapist and ask questions about the information presented. |
Participants attend attend six 60-minute sessions consisting of information and support across a range of cancer-related topics.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in patient relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in partner relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in partner relationship satisfaction measured by the Couples Satisfaction Inventory (higher scores indicate higher satisfaction) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in partner relationship functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in partner intimacy as measured by the Miller Social Intimacy Scale (higher scores indicate higher intimacy) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in partner psychological distress measured by the Hospital Anxiety and Depression Scale (higher scores indicate higher distress) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in partner mood as measured by the Positive and Negative Mood Scale (higher scores on the positive and negative mood subscales indicate higher negative and positive mood, respectively) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient life completion measured by the Life Completion scale of the QUAL-E (higher scores indicate higher completion) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in partner life completion measured by the Life Completion scale of the QUAL-E Family (higher scores indicate higher completion) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient physical well being as measured by the Physical Well Being subscale of the Functional Assessment of Cancer Therapy scale (higher scores indicate higher physical well being) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient and partner psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in symptom distress as measured by the Condensed Memorial Symptom Assessment Scale (higher scores indicate higher symptom distress) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient advance care planning discussions (presence or absence, via patient self-report) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient completion of advanced directives (presence or absence, via patient self-report) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient hospitalizations (number of hospitalizations per patient self-report, validated by medical record review) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
|
Changes in patient psychological functioning
時間枠:Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
Change in patient emergency department visits (number of emergency department visits per patient self-report, validated by medical record review) |
Baseline, end of intervention (up to 8 months), 3 month post intervention follow-up
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Laura Porter, PhD、Duke
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- Pro00103232
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。